• 16/09/2015

    Effect of Introducing Xpert MTB/RIF in Kazakhstan

    A pilot study was conducted in Kazakhstan to assess the effects of introducing the Xpert MTB/RIF (Xpert) diagnostic test to…

    Lees meer
  • 16/09/2015

    Expert exchange between Greece and the Netherlands

    Comparing TB Control in Greece and the Netherlands: an exchange full of surprises. In early 2015, Katerina Manika, lecturer in…

    Lees meer
  • 16/09/2015

    KNCV Symposium 24 September

    On Thursday, September 24, 2015, at its Annual Symposium ‘Innovation is everything’, KNCV Tuberculosis Foundation presented the White Paper ‘…

    Lees meer
  • 03/06/2015

    Taking stock: a blog by Nick Blok

    After three months, with 72 interviews in 5 provinces, 10 districts and 11 communes, it is time to take stock…

    Lees meer
  • 11/11/2014

    Interview with Agnes Gebhard on Case finding and DOT in Vietnam.

    During the recent Union World Conference on Lung Health 2014 USAID’s CAP-TB interviewed Agnes Gebhard on “Case finding and DOT…

    Lees meer
  • 29/10/2014

    Maarten van Cleeff receives Karel Styblo Award

    At the Opening Ceremony of the 45th Union World Conference on Lung Health in Barcelona, Maarten van Cleeff (MD, MSc, PhD)…

    Lees meer
  • 09/10/2014

    KNCV awarded USAID flagship Challenge TB program

    KNCV Tuberculosis Foundation (KNCV) will be the prime partner for the United States Agency for International Development (USAID) in their…

    Lees meer
  • 28/01/2014

    Academic thesis: Molecular epidemiology of tuberculosis in Vietnam

    On 3 February 2014 Vietnamese microbiologist Mai Nguyet Thu Huyen will defend her PhD thesis entitled “Molecular epidemiology of tuberculosis…

    Lees meer
  • 23/11/2013

    EU approves urgently-needed new TB medicine

    Important advance in the battle against drug-resistant tuberculosis On Friday, delamanid, a new anti-TB drug developed by the Japanese Otsuka…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.